Related Experiment Video
Updated: Sep 4, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D
Yingmin Wu1,2, Zhuojia Chen3, Guoyou Xie1
1Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Abstract:
Studies on biological functions of RNA modifications such as N6-methyladenosine (m6A) in mRNA have sprung up in recent years, while the roles of N1-methyladenosine (m1A) in cancer progression remain largely unknown. We find m1A demethylase ALKBH3 can regulate the glycolysis of cancer cells via a demethylation activity dependent manner. Specifically, sequencing and functional studies confirm that ATP5D, one of the most important subunit of adenosine 5'-triphosphate synthase, is involved in m1A demethylase ALKBH3-regulated glycolysis of cancer cells. The m1A modified A71 at the exon 1 of ATP5D negatively regulates its translation elongation via increasing the binding with YTHDF1/eRF1 complex, which facilitates the release of message RNA (mRNA) from ribosome complex. m1A also regulates mRNA stability of E2F1, which directly binds with ATP5D promoter to initiate its transcription. Targeted specific demethylation of ATP5D m1A by dm1ACRISPR system can significantly increase the expression of ATP5D and glycolysis of cancer cells. In vivo data confirm the roles of m1A/ATP5D in tumor growth and cancer progression. Our study reveals a crosstalk of mRNA m1A modification and cell metabolism, which expands the understanding of such interplays that are essential for cancer therapeutic application.
Insights
N1-methyladenosine (m1A) demethylase ALKBH3 regulates cancer cell glycolysis by targeting ATP5D. This RNA modification impacts tumor growth and cancer progression, revealing a link between mRNA metabolism and cancer therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- While N6-methyladenosine (m6A) modifications in mRNA are well-studied, the role of N1-methyladenosine (m1A) in cancer progression is largely unknown.
- Understanding RNA modifications' impact on cellular metabolism is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the role of m1A demethylase ALKBH3 in cancer cell glycolysis.
- To elucidate the mechanism by which ALKBH3 regulates cancer cell metabolism and tumor growth.
Main Methods:
- Investigated ALKBH3's demethylase activity in cancer cell glycolysis.
- Utilized sequencing and functional studies to identify ATP5D as a key regulator.
- Employed the dm1ACRISPR system for targeted demethylation of ATP5D m1A.
- Performed in vivo experiments to assess the role in tumor growth.
Main Results:
- ALKBH3 regulates cancer cell glycolysis in a demethylation-dependent manner.
- m1A modification at A71 of ATP5D negatively impacts its translation elongation via YTHDF1/eRF1 complex.
- m1A also affects E2F1 mRNA stability, influencing ATP5D transcription.
- Targeted demethylation of ATP5D m1A enhances ATP5D expression and glycolysis, promoting tumor growth.
Conclusions:
- Reveals a novel mechanism linking mRNA m1A modification, specifically of ATP5D, to cancer cell glycolysis and progression.
- Highlights the interplay between RNA modification and cell metabolism as a potential therapeutic target in cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Biosynthesis of Nucleic Acids

